Tariffs Threaten to Raise Toilet Paper Prices and Quality
Get tomorrow's supply chain signal
Daily supply-chain brief. Free, unsubscribe anytime.
The signal
A recent analysis from NC State University highlights how proposed tariffs could have cascading effects on the tissue products supply chain, particularly for toilet paper manufacturers. The research indicates that tariffs on imported raw materials and finished goods could drive up production costs while simultaneously forcing manufacturers to reduce quality specifications—a troubling trade-off for consumers and retailers alike. For supply chain professionals, this development underscores the vulnerability of consumer staples to trade policy disruptions.
The tissue industry relies on efficient cross-border material flows, and tariff barriers force manufacturers to either absorb costs (squeezing margins) or pass them to retailers and consumers. The quality degradation risk adds another layer of complexity: suppliers may be incentivized to substitute cheaper materials or reduce softening agents and processing steps to maintain competitiveness. This analysis signals broader implications for procurement strategies.
Companies should urgently review their sourcing dependencies, evaluate domestically available alternatives, and model pricing scenarios under various tariff regimes. The tissue sector, though often overlooked, represents a meaningful test case for how tariffs ripple through essential consumer goods supply chains.
Frequently Asked Questions
What This Means for Your Supply Chain
What if tariffs increase input costs by 15-25%?
Model the impact of a 15-25% increase in procurement costs for imported tissue manufacturing inputs (pulp, chemicals, machinery) on total production cost, retail pricing, and gross margin. Simulate two scenarios: (A) manufacturer absorbs costs, reducing margin; (B) manufacturer passes costs to retailer, risking volume loss.
Run this scenarioWhat if manufacturers shift to lower-cost raw materials?
Simulate the supply chain impact of tissue manufacturers substituting premium pulp and softening agents with lower-cost alternatives to maintain pricing. Model effects on product quality perception, retailer reorder rates, consumer switching, and long-term market share for brands pursuing this strategy.
Run this scenarioWhat if domestic sourcing capacity cannot meet demand?
Model supply constraints if tissue manufacturers attempt to nearshore production or increase domestic input sourcing to avoid tariffs. Simulate lead time extensions, capacity bottlenecks at domestic suppliers, and inventory build requirements to maintain service levels during a transition period.
Run this scenarioGet the daily supply chain briefing
Top stories, Pulse score, and disruption alerts. No spam. Unsubscribe anytime.
